Emergent BioSolutions Inc. — Director's Dealing 2017

Feb 24, 2017

SEC Form 4/A — Form 4/A

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2016-04-01

Reporting Person: Kramer Robert (EVP, Corporate Services Divisi)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-04-01	Common Stock	M	11531	$14.41	Acquired	91607	Direct
2016-04-01	Common Stock	S	11531	$35.49	Disposed	80076	Direct
2016-04-01	Common Stock	M	3939	$14.67	Acquired	84015	Direct
2016-04-01	Common Stock	S	3939	$35.74	Disposed	80076	Direct
2016-04-01	Common Stock	M	17354	$28.09	Acquired	97430	Direct
2016-04-01	Common Stock	S	17354	$35.48	Disposed	80076	Direct
2016-04-01	Common Stock	M	5503	$29.00	Acquired	85579	Direct
2016-04-01	Common Stock	S	5503	$35.66	Disposed	80076	Direct
2016-04-01	Common Stock	S	445	$35.93	Disposed	79631	Direct
2016-04-01	Common Stock	S	1855	$35.80	Disposed	77776	Direct
2016-04-01	Common Stock	S	2945	$35.73	Disposed	74831	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-04-01	Stock Option	$14.41	M	11531	Acquired	2019-11-04	Common Stock (11531)	Direct
2016-04-01	Stock Option	$14.67	M	3939	Acquired	2020-03-11	Common Stock (3939)	Direct
2016-04-01	Stock Option	$28.09	M	17354	Acquired	2021-03-10	Common Stock (17354)	Direct
2016-04-01	Stock Option	$29.00	M	5503	Acquired	2022-03-09	Common Stock (5503)	Direct

Footnotes

F1: These sales were executed pursuant to a 10b5-1 trading plan adopted by the reporting person on February 29, 2016.

F2: Consists of an option granted under the company's stock incentive plan on November 5, 2012.

F3: Consists of an option granted under the company's stock incentive plan on March 12, 2013.

F4: Consists of an option granted under the company's stock incentive plan on March 11, 2014.

F5: Consists of an option granted under the company's stock incentive plan on March 10, 2015.

F6: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.11 to $36.34, inclusive.

F7: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.37 to $36.32, inclusive.

F8: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.07 to $36.35, inclusive.

F9: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.12 to $36.42, inclusive.

F10: Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.

F11: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.91 to $36.00, inclusive.

F12: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.50 to $36.13, inclusive.

F13: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.50 to $36.32, inclusive.

F14: The option vested in three equal installments in November 2013, 2014 and 2015.

F15: The option vest in three equal installments in March 2014, 2015 and 2016.

F16: The option vest in three equal installments in March 2015, 2016 and 2017.

F17: The option vest in three equal installments in March 2016, 2017 and 2018.